Continuation of Research and Development Activities
First written in FY2017-Q1. 23 of 34 entries say "Restated". Latest entry: FY2026.
45 other companies' latest entry also says "Other".
- FY2026Update to full-year research and development expensesAnnual report
「Research and development expenses by segment for the current consolidated fiscal year totaled ¥44 million, primarily in Japan.」
Research and development based on proprietary technology, subsidiary technologies and collaboration with procurement companies is continuing, and full-year research and development expenses were disclosed as ¥44 million. - FY2026-H1Update to interim research and development expenses for the 74th fiscal yearAnnual report
「The amount spent on group-wide research and development activities during the current consolidated interim accounting period was ¥23 million. There were no material changes in the status of the Group's research and development activities during the current consolidated interim accounting period.」
Cumulative interim research and development expenses were disclosed as ¥23 million, and the Company explained that there were no material changes in the status of R&D activities. - FY2025Update to full-year research and development expensesAnnual report
「Research and development expenses by segment for the current consolidated fiscal year totaled ¥87 million, primarily in Japan.」
Research and development based on proprietary technology, subsidiary technologies and collaboration with procurement companies is continuing, and full-year research and development expenses reached ¥87 million. - FY2025-H1RestatedAnnual report
「The amount spent on group-wide research and development activities during the current consolidated interim accounting period was ¥39 million. There were no material changes in the status of the Group's research and development activities during the current consolidated interim accounting period.」
Cumulative interim research and development expenses were updated to ¥39 million, while the Company explained that there were no material changes in the status of R&D activities. - FY2024Update to full-year research and development expensesAnnual report
「Research and development expenses by segment for the current consolidated fiscal year totaled ¥61 million, primarily in Japan.」
Research and development based on proprietary technology, subsidiary technologies and collaboration with procurement companies is continuing, and full-year research and development expenses were disclosed as ¥61 million. - FY2024-Q3Update to cumulative research and development expenses for the third quarter of the 72nd fiscal yearAnnual report
「The amount spent on group-wide research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥47 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
Research and development expenses were updated from ¥42 million in the same period of the previous fiscal year to ¥47 million, while the Company explained that there were no material changes in the status of R&D activities. - FY2024-Q1RestatedAnnual report
「The Group's total research and development expenditure for the cumulative consolidated period through the first quarter was ¥22 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenses were updated to ¥22 million, while the Company explained that there were no material changes in the status of R&D activities. - FY2023Update to full-year research and development expensesAnnual report
「Research and development expenses by segment for the current consolidated fiscal year totaled ¥70 million, primarily in Japan.」
Research and development based on proprietary technology, subsidiary technologies and collaboration with procurement companies is continuing, and full-year research and development expenses reached ¥70 million. This was an increase from ¥51 million in the previous fiscal year. - FY2023-Q3RestatedAnnual report
「The amount spent on group-wide research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥42 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
Cumulative research and development expenses for the third quarter of the 71st fiscal year were updated to ¥42 million, while the Company explained that there were no material changes in the status of R&D activities. - FY2023-Q2RestatedAnnual report
「The amount spent on group-wide research and development activities during the cumulative second quarter of the current consolidated fiscal year was ¥25 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
Cumulative research and development expenses for the second quarter of the 71st fiscal year were disclosed as ¥25 million, and the Company explained that there were no material changes in the status of R&D activities. - FY2023-Q1RestatedAnnual report
「The Group's total research and development activities during the three-month period ended the first quarter amounted to ¥7 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended the first quarter.」
Research and development expenses were updated to ¥7 million for the first quarter of the 71st fiscal year, while the Company explained that there were no material changes in the status of R&D activities. - FY2022Update to full-year research and development expensesAnnual report
「Research and development expenses by segment for the current consolidated fiscal year totaled ¥51 million, primarily in Japan.」
Research and development based on proprietary technology, subsidiary technologies and collaboration with procurement companies is continuing, and full-year research and development expenses were disclosed as ¥51 million. - FY2022-Q3Update to cumulative research and development expenses for the third quarter of the 70th fiscal yearAnnual report
「The amount spent on group-wide research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥35 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
Cumulative research and development expenses for the third quarter of the 70th fiscal year were disclosed as ¥35 million, and the Company explained that there were no material changes in the status of R&D activities. - FY2022-Q1RestatedAnnual report
「Group-wide R&D activities during the three-month period ended Q1 amounted to ¥10 million. There were no significant changes in the status of the Group's R&D activities during the three-month period ended Q1.」
Research and development expenses for the first quarter of the 70th fiscal year were updated to ¥10 million, and the Company explained that there were no material changes in the status of R&D activities. - FY2021Update to full-year research and development expensesAnnual report
「Research and development expenses by segment for the current consolidated fiscal year totaled ¥52 million, primarily in Japan.」
Research and development based on proprietary technology, subsidiary technologies and collaboration with procurement companies is continuing, and full-year research and development expenses were disclosed as ¥52 million. - FY2021-Q3RestatedAnnual report
「The amount spent on group-wide research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥36 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
Cumulative research and development expenses for the third quarter were updated to ¥36 million, while the Company explained that there were no material changes in the status of R&D activities. - FY2021-Q2RestatedAnnual report
「The amount spent on group-wide research and development activities during the cumulative second quarter of the current consolidated fiscal year was ¥23 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
Research and development expenses were updated to ¥23 million, and the Company explained that there were no material changes in the status of R&D activities. - FY2021-Q1RestatedAnnual report
「The amount spent on group-wide research and development activities during the cumulative first quarter of the current consolidated fiscal year was ¥11 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
Research and development expenses were updated to ¥11 million, and the Company explained that there were no material changes in the status of R&D activities. - FY2020Update to full-year research and development expensesAnnual report
「Research and development expenses by segment for the current consolidated fiscal year totaled ¥40 million, primarily in Japan.」
Research and development based on proprietary technology, subsidiary technologies and collaboration with procurement companies is continuing, and full-year research and development expenses were disclosed as ¥40 million. - FY2020-Q3RestatedAnnual report
「The amount spent on group-wide research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥30 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
Research and development expenses were updated to ¥30 million, while the Company explained that there were no material changes in the status of R&D activities. - FY2020-Q2RestatedAnnual report
「Group-wide R&D activities during the six-month period ended Q2 amounted to ¥21 million. There were no significant changes in the status of the Group's R&D activities during the six-month period ended Q2.」
Research and development expenses were updated to ¥21 million, while the Company explained that there were no material changes in the status of R&D activities. - FY2020-Q1RestatedAnnual report
「The amount spent on group-wide research and development activities during the cumulative first quarter of the current consolidated fiscal year was ¥11 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
Research and development expenses were updated to ¥11 million, while the Company explained that there were no material changes in the status of R&D activities. - FY2019RestatedAnnual report
「Our Group is engaged in research and development activities aimed at creating strengths unique to the Company through our proprietary press-fit projection joining technology, various technologies held by subsidiaries including precision cold forging technology, and collaboration with procurement companies.」
Research and development based on proprietary technology, subsidiary technologies and collaboration with procurement companies is continuing. Research and development expenses for the current fiscal year are ¥42 million. - FY2019-Q3RestatedAnnual report
「The amount spent on group-wide research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥29 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
Research and development expenses were updated to ¥29 million, while the Company explained that there were no material changes in the status of R&D activities. - FY2019-Q2RestatedAnnual report
「The amount spent on group-wide research and development activities during the cumulative second quarter of the current consolidated fiscal year was ¥20 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
Research and development expenses were updated to ¥20 million, while the Company explained that there were no material changes in the status of R&D activities. - FY2019-Q1RestatedAnnual report
「The Group's total research and development activities during the three-month period ended the first quarter amounted to ¥8 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended the first quarter.」
Research and development expenses were updated to ¥8 million, while the Company explained that there were no material changes in the status of R&D activities. - FY2018RestatedAnnual report
「Our Group is engaged in research and development activities aimed at creating strengths unique to the Company through our proprietary press-fit projection joining technology, various technologies held by subsidiaries including precision cold forging technology, and collaboration with procurement companies.」
Research and development based on proprietary technology, subsidiary technologies and collaboration with procurement companies is continuing. Research and development expenses for the current fiscal year are ¥47 million. - FY2018-Q3RestatedAnnual report
「The amount spent on group-wide research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥30 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
Research and development expenses were updated to ¥30 million for the cumulative third quarter, while the Company explained that there were no material changes in the status of R&D activities. - FY2018-Q2RestatedAnnual report
「The amount spent on group-wide research and development activities during the cumulative second quarter of the current consolidated fiscal year was ¥20 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
It updates research and development expenses while explicitly stating that there were no material changes in R&D activities. - FY2018-Q1RestatedAnnual report
「The amount spent on group-wide research and development activities during the cumulative first quarter of the current consolidated fiscal year was ¥11 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」
It updates research and development expenses while explicitly stating that there were no material changes in R&D activities. - FY2017RestatedAnnual report
「Our Group is engaged in research and development activities aimed at creating strengths unique to the Company through our proprietary press-fit projection joining technology, various technologies held by subsidiaries including precision cold forging technology, and collaboration with partner companies.」
Research and development based on proprietary technology, subsidiary technologies and collaboration with partner companies is continuing. Annual research and development expenses are approximately ¥50 million. - FY2017-Q3RestatedAnnual report
「The amount spent on group-wide research and development activities during the cumulative third quarter of the current consolidated fiscal year was ¥37 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」
It updates research and development expenses while explicitly stating that there were no material changes in R&D activities. - FY2017-Q2RestatedAnnual report
「The amount spent on group-wide research and development activities during the cumulative second quarter of the current consolidated fiscal year was ¥26 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」
It discloses research and development expenses for the current quarter while stating that there were no material changes in R&D activities. - FY2017-Q1First statedAnnual report
「The amount of research and development activities for the group as a whole during the cumulative first quarter of the current consolidated fiscal year was ¥13 million.」
The note reports research and development expenses for the current quarter and states that there were no material changes in R&D activities.